Ryan Noble compensation by year
Kewaunee Scientific Summary Compensation Table · all 2 fiscal years held| Component | FY2019 | FY2020 |
|---|---|---|
| Salary | $175,000 | $223,667 |
| Bonus | $38,610 | $33,660 |
| Stock awards | $64,374 | $58,764 |
| Option awards | $0 | $0 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $61,180 | $17,783 |
| Total | $339,164 | $333,874 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Kewaunee Scientific Corp DEF 14A filed July 29, 2020, accession 0001193125-20-201715, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Kewaunee Scientific Corp filed document, accession 0001193125-20-201715. Every figure is read from that document and cited to the page and table it appears in. Filed July 29, 2020.
Equity holdings
unvested awards at FY2020 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 2,561 | $27,582 | — |
| RSU | 732 | $7,884 | — |
| PSU | 690 | $7,431 | — |
| RSU | 197 | $2,122 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Kewaunee Scientific Corp's FY2020 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
14 Form 4 lines since the FY2020 proxy (filed July 29, 2020)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-06-30 | Tax withholding | — | 1,809 | $36.25 | 16,240 |
| 2026-06-30 | Exercise or conversion derivative | — | 730 | $0.00 | 3,650 |
| 2026-06-30 | Disposition to the issuer | — | 3,000 | $36.25 | 18,049 |
| 2026-06-30 | Exercise or conversion derivative | — | 2,942 | $0.00 | 0 |
| 2026-06-30 | Exercise or conversion derivative | — | 534 | $0.00 | 2,939 |
| 2026-06-30 | Exercise or conversion | — | 7,206 | $0.00 | 21,049 |
| 2026-06-24 | Grant or award derivative | — | 2,628 | $0.00 | 2,628 |
| 2025-07-01 | Tax withholding | — | 939 | $58.34 | 13,843 |
The 8 most recent of 14 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Kewaunee Scientific’s named executive officers, FY2020
as the company reported each| Named executive officer | Role | FY2020 total |
|---|---|---|
| Thomas Hull III | President and Chief Executive Officer | $674,030 |
| Donald Gardner III | Vice President Finance and Chief Financial Officer | $512,959 |
| Ryan Noble · this page | Vice President, Sales and Marketing | $333,874 |
| Mandar Ranade | Vice President of Information Technology | $231,996 |
The full Kewaunee Scientific compensation record
free company briefThis page is one person within Kewaunee Scientific's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Kewaunee Scientific's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.